Found on pharmacist.com
Group by:
Title Date Type
FDA official says ongoing blood pressure drug investigation will probably uncover more tainted drugs
CNN.com (02/22/19) Scutti, Susan
Janet Woodcock, MD, director of FDA's Center for Drug Evaluation and Research, reports the agency is continuing an investigation and recall of a class of drugs used by millions that began last summer. Starting in July, separate lots of blood pressure medications from various companies were pulled…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
FDA adds boxed warning for increased risk of death with gout medicine febuxostat
FDA Drug Safety Communication (02/21/19)
FDA is updating the prescribing information for the gout drug febuxostat (Uloric—Takeda) after concluding it has an increased risk of death compared with another gout drug, allopurinol. The febuxostat prescribing information now requires a boxed warning about the increased risk of heart-…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
Once-daily plazomicin for complicated UTIs
New England Journal of Medicine (02/21/19) Vol. 380, No. 8, P. 729 Wagenlehner, Florian M.E.; Cloutier, Daniel J.; Komirenko, Allison S.; et al.
Plazomicin holds promise for treating serious infections at a time when multidrug resistance among gram-negative uropathogens is on the rise. To test its noninferiority against meropenem in the setting of complicated urinary tract infection, researchers assembled a sample of 388 patients. Each was…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
New England Journal of Medicine (02/21/19) Vol. 380, No. 8, P. 720 Khorana, Alok A.; Soff, Gerald A.; Kakkar, Ajay K.; et al.
The CASSINI randomized trial explored whether thromboprophylaxis would benefit ambulatory patients undergoing systemic cancer therapy, who face varying risk for venous thromboembolism. The researchers recruited 841 high-risk patients without deep-vein thrombosis, allocating 420 to take daily…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
Purdue's Sackler embraced plan to conceal oxycodone's strength, sealed deposition shows
STAT News (02/21/19) Armstrong, David
In May 1997, the year after Purdue Pharma launched oxycodone (OxyContin), Michael Friedman, the company's head of sales and marketing, told Richard Sackler, a member of the billionaire family that founded and controls the company, that he did not want to correct the false impression among doctors…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
Walgreens orders wake-up call for Americans not taking their medication
Medical Marketing & Media (02/22/19) Kanski, Alison
Wake Up Call, a new campaign from Walgreens, aims to increase medication adherence. "There are several factors that cause patients to not take their medication," said Adam Holyk, SVP and chief marketing officer at Walgreens. "Some of the most important ones when we think about patients with chronic…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
Rite Aid and GNC extend partnership
Chain Drug Review (02/19/19)
Rite Aid and GNC have inked an agreement to extend their exclusive partnership, which began in December 1998, through 2022. "Our more than 20-year partnership with GNC has provided Rite Aid with a key point of differentiation in the marketplace while strengthening our reputation as a health and…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
FDA advances new proposed regulation to make sure that sunscreens are safe and effective
FDA News Release (02/21/19)
A proposed rule from FDA would update regulatory requirements for most sunscreens in the United States. The proposal focuses on sunscreen active ingredient safety, dosage forms, and sun protection factor and broad-spectrum requirements, and it proposes updates to how products are labeled to make…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
FDA taking additional steps to support the development of safe and effective novel nicotine replacement therapies
FDA News Release (02/21/19) Gottlieb, Scott
FDA Commissioner Scott Gottlieb, MD, said Thursday the agency has issued draft guidance that helps lay out a framework for new potential clinically relevant outcomes for smoking cessation products. The draft guidance, "Smoking Cessation and Related Indications: Developing Nicotine Replacement…
Feb 21, 2019 Publication Pharmacy Today Daily Edition
How drug prices could derail new trade pact to replace NAFTA
Associated Press (02/21/19) Wiseman, Paul
As Democrats in Congress consider whether to back a revamped regional trade pact being pushed by President Donald Trump, they are zeroing in on drug prices. Many contend that the new pact would force Americans to pay more for prescription drugs, and their argument has dimmed the outlook for one of…
Feb 21, 2019 Publication Pharmacy Today Daily Edition